Menu Search
Equities

Bumrungrad Hospital PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BUHHF:PKL

Bumrungrad Hospital PCL

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta0.8089
Data delayed at least 15 minutes.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Bumrungrad Hospital Public Company Limited is a Thailand-based company, which operates a private hospital, namely Bumrungrad International hospital in Bangkok, which serves both local and international wards. The Company provides complete healthcare services for both outpatients and inpatients and also invests in the related healthcare services businesses. Its Telemedicine service provides consultation through information technology to support remote access consultation. Its preventive genomics and family check-up services provide diagnosis, treatment, and advice, including risk assessment and screening for diseases caused by genetic abnormalities. Its Bumrungrad@Home service provides health care services. Its Breast Center delivers holistic medical services regarding breast health for all genders. Its sports medicine and joint center offer an integrated approach to treating musculoskeletal problems.

  • Revenue in THB (TTM)25.07bn
  • Net income in THB7.53bn
  • Incorporated1993
  • Employees4.23k
  • Location
    Bumrungrad Hospital PCL33 Sukhumvit Soi 3 (Nana Nua)Sukhumvit Road, Klongtoey Nua, WatthanaBANGKOK 10110ThailandTHA
  • Phone+66 26671000
  • Fax+66 26672525
  • Websitehttps://www.bumrungrad.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.